These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6469754)

  • 41. Radiosensitization by a new nucleoside analogue: 1-[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl-2-nitroimidazole (RP-170).
    Murayama C; Suzuki A; Suzuki T; Miyata Y; Sakaguchi M; Tanabe Y; Tanaka N; Mori T
    Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):575-81. PubMed ID: 2528527
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The use of hypoxic cell radiosensitizers with mixed X and alpha radiations.
    Raju MR; Frank JP; Bain E; Trujillo TT
    Radiat Res; 1977 Jul; 71(1):233-9. PubMed ID: 560028
    [No Abstract]   [Full Text] [Related]  

  • 43. Radiosensitization by a new potent nucleoside analog: 1-(1',3',4'-trihydroxy-2'-butoxy)methyl-2-nitroimidazole(RP-343).
    Murayama C; Suzuki A; Sato C; Tanabe Y; Shoji T; Miyata Y; Nishio A; Suzuki T; Sakaguchi M; Mori T
    Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):433-43. PubMed ID: 8514541
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro and in vivo radiosensitizing effects of 2-nitroimidazole derivatives with sugar component.
    Murayama C; Tanaka N; Miyamoto Y; Sakaguchi M; Mori T
    Strahlenther Onkol; 1987 Jun; 163(6):385-90. PubMed ID: 3603366
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vivo radiosensitizing effect of nitroimidazole derivative KIN-804.
    Tada T; Nakajima T; Onoyama Y; Murayama C; Mori T; Nagasawa H; Hori H; Inayama S
    Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):601-5. PubMed ID: 8005823
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of combinations of nitroaromatic and nitroxyl radiosensitizers on the radiation survival response of Chinese hamster cells, V.79-753B, in vitro.
    Millar BC; Fielden EM; Jenkins TC
    Radiat Res; 1981 Nov; 88(2):369-76. PubMed ID: 7302142
    [No Abstract]   [Full Text] [Related]  

  • 47. Pharmacokinetic and metabolic studies of the hypoxic cell radiosensitizer misonidazole.
    Flockhart IR; Large P; Troup D; Malcolm SL; Marten TR
    Xenobiotica; 1978 Feb; 8(2):97-105. PubMed ID: 415443
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of heat on the intracellular uptake and radiosensitization of 2-nitroimidazole hypoxic cell sensitizers in vitro.
    Brown DM; Cohen MS; Sagerman RH; Gonzalez-Mendez R; Hahn GM; Brown JM
    Cancer Res; 1983 Jul; 43(7):3138-42. PubMed ID: 6850622
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differences in the toxicity and metabolism of the 2-nitroimidazole misonidazole (Ro-07-0582) in HeLa and Chinese hamster ovary cells.
    Taylor YC; Rauth AM
    Cancer Res; 1978 Sep; 38(9):2745-52. PubMed ID: 679180
    [No Abstract]   [Full Text] [Related]  

  • 50. [Radiosensitizing effect of a 2-nitroimidazole hydroxamate (KIN-804) to murine tumors].
    Tada T; Nakajima T; Onoyama Y; Nagasawa H; Hori H; Inayama S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 May; 52(5):688-90. PubMed ID: 1508643
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of hypoxia on the cytotoxicity of misonidazole in HELA S3 cells in vitro.
    Ohizumi Y; Shibata C; Mori T
    Gan; 1980 Jun; 71(3):319-24. PubMed ID: 7418978
    [TBL] [Abstract][Full Text] [Related]  

  • 52. NLA-1: a 2-nitroimidazole radiosensitizer targeted to DNA by intercalation.
    Denny WA; Roberts PB; Anderson RF; Brown JM; Phil D; Wilson WR
    Int J Radiat Oncol Biol Phys; 1992; 22(3):553-6. PubMed ID: 1735695
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NLP-1: a DNA intercalating hypoxic cell radiosensitizer and cytotoxin.
    Panicucci R; Heal R; Laderoute K; Cowan D; McClelland RA; Rauth AM
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1039-43. PubMed ID: 2703383
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparison of the cytological effects of three hypoxic cell radiosensitizers.
    Spunberg JJ; Geard CR; Rutledge-Freeman MH
    Int J Radiat Oncol Biol Phys; 1982 Jul; 8(7):1207-15. PubMed ID: 6214532
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Azomycin riboside: a new radiosensitizer.
    Pedersen JE; Barron G; Chapman JD
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):415-8. PubMed ID: 7107360
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo testing of hypoxic radiosensitizers using the KHT murine tumour assayed by the lung-colony technique.
    Rauth AM; Kaufman K
    Br J Radiol; 1975 Mar; 48(567):209-20. PubMed ID: 1125550
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of the fate of misonidazole (RO 07-0582) and its metabolite desmethylmisonidazole (RO 05-9963), two hypoxic cell radiosensitizers: penetration properties in tumor bearing rats.
    Akel G; Canal P; Mockey E; Vandevoorde E; Laurent F; Soula G
    J Pharmacol; 1983; 14(1):67-77. PubMed ID: 6834852
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hyperthermia enhances the cytotoxicity against hypoxic cells of RP-170, a new 2-nitroimidazole nucleoside hypoxic cell sensitizer.
    Emi Y; Maehara Y; Kusumoto T; Baba H; Sakaguchi M; Sugimachi K
    Oncology; 1995; 52(1):55-9. PubMed ID: 7800343
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 9-[3-(2-Nitro-1-imidazolyl)propylamino]-1,2,3,4-tetrahydroacridine hydrochloride. A novel DNA-affinic hypoxic cell cytotoxin and radiosensitizer. Comparison with NLA-1.
    Papadopoulou MV; Rosenzweig HS; Doddi M; Bloomer WD
    Oncol Res; 1994; 6(9):439-48. PubMed ID: 7703530
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of X-ray-induced potentially lethal damage (PLD) repair in aerobic plateau-phase Chinese hamster cells by misonidazole.
    Brown DM; Dionet C; Brown JM
    Radiat Res; 1984 Jan; 97(1):162-70. PubMed ID: 6229806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.